| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Hbm Healthcare Investments (cayman) Ltd. last filed a Form 4 in February 2023, as 10% Owner at MLYS. The filings on record cover 3 companies.
At the last filing, the largest reported position was 3,218,106 shares of MLYS. Net of sales, the MLYS filings show accumulation of 312,500 shares.
Hbm Healthcare Investments (cayman) Ltd. has 3 Form 4 filings on record from May 2021 to February 2023, across 3 companies: 10% Owner at Mineralys Therapeutics (MLYS), 2023; 10% Owner at IO Biotech (IOBT), 2021; 10% Owner at Werewolf Therapeutics (HOWL), 2021.
The 6 reported transactions were 4 conversions and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $9.6M and no sales.
The largest open-market purchase was 312,500 shares of MLYS at an average $16.00 on February 14, 2023, about $5.0M. Twelve months later MLYS was down 19%.
Shares as reported in the last Form 4 for each company; the most recent is from February 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.